Brandi is currently Advisory Board’s Vice President of Life Sciences and Health Care Ecosystem Research. In this capacity, she oversees all of Advisory Board’s research, training, and interactive experiences for life sciences and digital health companies’ medical, commercial, and learning and development teams. She assumed this position in early 2019, after devoting 14+ years to building out Advisory Board’s “customer insight” research subscription for commercial leaders of life sciences, digital health, and health care services firms.
In Fall 2018, her team launched the Medical Affairs Leadership Council—a subscription research membership designed to help medical affairs executives (from pharma and device) create more compelling, impactful medical value narratives for payers and HCPs. Prior to that work, she launched the firm’s Sales Transformation Support Initiative to help suppliers’ key accounts teams engage with health system leaders more effectively. After writing Twelve Surprising Truths about Engaging Hospital Purchasers and What Your Hospital Customers Really Want, Brandi has become a sought-after speaker on customer value frameworks, provider-supplier partnerships, IDN purchasing trends, and outcomes-based contracts.
While leading Advisory Board’s research for life sciences, Brandi also helped to launch membership programs for health services firms, independent physician groups, and post-acute care providers. Across all these research memberships—including Advisory Board’s newest offering for leaders of U.S. medical affairs teams—Brandi’s goal has been the same: to share the insights and best practices that make it easier for health care organizations to understand each other’s perspectives, find common ground, and work more effectively together.
Prior to work at Advisory Board, Brandi was a Practice Manager with the Los Angeles office of the Boston Consulting Group. While at BCG, she supported clients in the biopharmaceutical, medical device, and health care delivery sectors. She has led major organizational redesign efforts to improve drug commercialization, clinical trials management, and operating room efficiency.
Brandi received her MBA from the Stanford Graduate School of Business, where she graduated as an Arjay Miller scholar. She also holds an MA in Rhetoric from Duke University and an AB with honors in English and American Studies from Stanford University.